Coherus Biosciences | CHRS - Acción





Acción Cambio Fecha
AbbVie USD 5.05B 98M 2026-03
Acadia Pharmaceuticals USD 31.57M 3.1M 2026-03
Akebia Therapeutics USD 13M 2.61M 2026-03
ALKERMES USD 298.96M 37.75M 2026-06
Alnylam Pharmaceuticals USD 97.11M 103.04M 2026-06
Amarin USD 164.07M 19.51M 2026-06
Amgen USD 6.19B 39M 2026-03
Baxter International USD 2.26B 57M 2026-06
Biogen USD 2.38B 435.3M 2026-06
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Bristol-Myers Squibb USD 2.74B 19M 2026-06
Coherus Biosciences USD 3.17M 1.12M 2025-12
Eli Lilly USD 14.53B 785M 2026-03
Fujifilm JPY 600.12B 1.55B 2025-09
Gilead Sciences USD 1.91B 140M 2026-03
Merck USD 6.48B 179M 2026-03
Myriad Genetics USD 30.6M 2.7M 2026-06
Pacira USD 150.37M 2.49M 2026-03
Perrigo USD 1.12B 27.6M 2026-03
Pfizer USD 10.67B 13M 2026-03
PTC Therapeutics USD 91.35M 15.79M 2026-06
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Sarepta Therapeutics USD 1B 86.37M 2026-03
Teva Pharmaceutical Industries USD 3.18B 3M 2026-03
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03
Zoetis USD 2.55B 120M 2026-03